Treatment with Lutathera significantly beneficial for patients with midgut NETs

23 Oct 2017


According to a new study presented at the North American Neuroendocrine Tumour Society annual meeting, 177Lu-dotatate can substantially benefit quality of life for patients with midgut neuroendocrine tumours.

MedPage Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story